Home › Agent Hub › Agent Tools › Part D coverage by drug › Amlodipine / Olmesartan
Agent Tools
Amlodipine / Olmesartan is a generic drug. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 5,128 of 5,492 Medicare Part D and Medicare Advantage drug plans (93.4%) list Amlodipine / Olmesartan on their formulary, across 259 of 286 formularies. The most common placement is tier 1 (4,163 plans, 81.2% of those covering it). 0 of the covering plans require prior authorization (0%), 0 step therapy and 4,316 a quantity limit.
4,830 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $0, 4,575 of them $0; 298 charge coinsurance instead — median 25% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 5,016 of 5,496 plans covered it (91.3%); 2027: 5,128 of 5,492 (93.4%).
Of 4,367 plans offered in both years, 93 added it to the formulary and 9 dropped it.
Among plans covering it both years, 40 moved it to a higher tier and 238 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 4,163 |
| Tier 2 | 258 |
| Tier 3 | 76 |
| Tier 4 | 32 |
| Tier 5 | 3 |
| Tier 6 | 596 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 173 of 323 | 53.6% | 0% |
| Medicare Advantage with drugs (MA-PD) | 3,059 of 3,200 | 95.6% | 0% |
| Special needs plans (SNP) | 1,896 of 1,969 | 96.3% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 778 of 846 | Tier 1 | 0 |
| UnitedHealthcare | 830 of 830 | Tier 1 | 0 |
| Devoted Health | 728 of 728 | Tier 1 | 0 |
| Aetna Medicare | 631 of 631 | Tier 1 | 0 |
| Wellcare | 234 of 268 | Tier 6 | 0 |
| HealthSpring | 186 of 226 | Tier 1 | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 83 of 83 | Tier 2 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 2 | 0 |
| Alignment Health Plan | 77 of 77 | Tier 6 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 1 | 0 |
| Wellpoint | 63 of 63 | Tier 1 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 1 | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 1 | 0 |
| Zing Health | 36 of 36 | Tier 1 | 0 |
| Capital Blue Cross | 35 of 35 | Tier 3 | 0 |
| Prominence Health Plan | 0 of 29 | No tier listed | 0 |
| Medica | 27 of 27 | Tier 1 | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 1 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 1 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 109 of 114 | 95.6% |
| Alaska | 5 of 9 | 55.6% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 140 of 147 | 95.2% |
| Arkansas | 80 of 85 | 94.1% |
| California | 345 of 397 | 86.9% |
| Colorado | 91 of 106 | 85.8% |
| Connecticut | 49 of 54 | 90.7% |
| Delaware | 39 of 43 | 90.7% |
| District of Columbia | 9 of 12 | 75% |
| Florida | 505 of 545 | 92.7% |
| Georgia | 137 of 149 | 91.9% |
| Guam | 1 of 1 | 100% |
| Hawaii | 40 of 50 | 80% |
| Idaho | 33 of 45 | 73.3% |
| Illinois | 126 of 132 | 95.5% |
| Indiana | 131 of 138 | 94.9% |
| Iowa | 60 of 64 | 93.8% |
| Kansas | 79 of 84 | 94% |
| Kentucky | 117 of 121 | 96.7% |
| Louisiana | 121 of 125 | 96.8% |
| Maine | 48 of 52 | 92.3% |
| Maryland | 35 of 49 | 71.4% |
| Massachusetts | 84 of 89 | 94.4% |
| Michigan | 178 of 182 | 97.8% |
| Minnesota | 59 of 63 | 93.7% |
| Mississippi | 100 of 104 | 96.2% |
| Missouri | 163 of 170 | 95.9% |
| Montana | 21 of 27 | 77.8% |
| Nebraska | 44 of 51 | 86.3% |
| Nevada | 83 of 100 | 83% |
| New Hampshire | 21 of 25 | 84% |
| New Jersey | 68 of 73 | 93.2% |
| New Mexico | 60 of 68 | 88.2% |
| New York | 211 of 215 | 98.1% |
| North Carolina | 167 of 176 | 94.9% |
| North Dakota | 22 of 26 | 84.6% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 167 of 171 | 97.7% |
| Oklahoma | 76 of 81 | 93.8% |
| Oregon | 83 of 92 | 90.2% |
| Pennsylvania | 316 of 323 | 97.8% |
| Puerto Rico | 53 of 64 | 82.8% |
| Rhode Island | 24 of 29 | 82.8% |
| South Carolina | 85 of 89 | 95.5% |
| South Dakota | 26 of 30 | 86.7% |
| Tennessee | 151 of 156 | 96.8% |
| Texas | 388 of 407 | 95.3% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 49 of 53 | 92.5% |
| Vermont | 9 of 14 | 64.3% |
| Virginia | 134 of 144 | 93.1% |
| Washington | 94 of 114 | 82.5% |
| West Virginia | 65 of 69 | 94.2% |
| Wisconsin | 91 of 96 | 94.8% |
| Wyoming | 9 of 13 | 69.2% |
Medicare Part D paid for 851,576 30-day fills of Amlodipine / Olmesartan in 2024 for about 94,147 enrollees, at an average total cost of $20.01 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Amlodipine / Olmesartan and the rest of a client's list on every plan in their county.
Estimate Amlodipine / Olmesartan costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.